Literature DB >> 19219399

Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey--a multicenter study.

Tatsuo Araida1, Ryouta Higuchi, Mie Hamano, Yoshihito Kodera, Nobuhiro Takeshita, Takehiro Ota, Tatsuya Yoshikawa, Masakazu Yamamoto, Ken Takasaki.   

Abstract

PURPOSE: We conducted this study to evaluate the optimal hepatic resection for pT2 and pT3 advanced carcinoma of the gallbladder without invasion of the hepatoduodenal ligament.
METHODS: We conducted a questionnaire survey regarding 4,243 cases of carcinoma of the gallbladder treated during the recent 10-year period at 112 institutions belonging to the Japanese Society of Biliary Surgery. The questionnaires included questions on preoperative-diagnosis, complications, treatment, and surgical treatment, procedures of resection, surgical result, path histological findings, mode, and site of recurrence, additional post-operative treatment. They included 293 pT2 and 192 pT3 R0 cases, which were negative for hepatoduodenal ligament invasion, and the cumulative survival rates and sites of postoperative recurrence in the form of liver metastasis, were retrospectively analyzed in these 485 cases. RESULT: There were no significant differences in survival rate or recurrence rates in the form of liver metastasis between the groups that underwent resection of the gallbladder bed, the group that underwent segmentectomy 4a+5, and the group that underwent hepatectomy in patients with of both pT2 or pT3 gallbladder cancers. Our results also did not show that liver metastasis to segment 4a5 alone was particularly common.
CONCLUSION: For gallbladder cancer, neither with hepatoduodenal ligament invasion nor hepatic invasion, resection of the gallbladder bed is more preferable for surgical hepatic procedure. For gallbladder cancer that invades any hepatic sites, a hepatic surgical procedure that could eliminate surgical margins would be desirable.

Entities:  

Mesh:

Year:  2009        PMID: 19219399     DOI: 10.1007/s00534-009-0044-3

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  22 in total

1.  Relevance of residual disease after liver resection for incidental gallbladder cancer.

Authors:  Javier C Lendoire; Luis Gil; Fernando Duek; Carlos Quarin; Verónica Garay; Gabriel Raffin; Marcelo Rivaldi; Oks Alejandra; Oscar Imventarza
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

2.  Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer.

Authors:  T Tsirlis; F Ausania; S A White; J J French; B C Jaques; R M Charnley; D M Manas
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

3.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

4.  Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary?

Authors:  Sae Byeol Choi; Hyung Joon Han; Wan Bae Kim; Tae Jin Song; Sung Ock Suh; Sang Yong Choi
Journal:  Langenbecks Arch Surg       Date:  2013-09-21       Impact factor: 3.445

5.  Audit of management of gallbladder cancer in a Nigerian tertiary health facility.

Authors:  O I Alatise; O O Lawal; A O Adisa; O A Arowolo; O O Ayoola; E A Agbakwuru; A R K Adesunkanmi; G O Omoniyi-Esan; O O Olaofe
Journal:  J Gastrointest Cancer       Date:  2012-09

6.  [Incidental T1b-T3 gallbladder carcinoma. Extended cholecystectomy as an underestimated prognostic factor-results of the German registry].

Authors:  T O Goetze; V Paolucci
Journal:  Chirurg       Date:  2014-02       Impact factor: 0.955

7.  Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group.

Authors:  Ryusei Matsuyama; Kenichi Matsuo; Ryutaro Mori; Mitsutaka Sugita; Naotaka Yamaguchi; Toru Kubota; Kunio Kameda; Yasuhisa Mochizuki; Ryo Takagawa; Toshiaki Kadokura; Goro Matsuda; Noriyuki Kamiya; Itaru Endo
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

8.  Hepatectomy of segment 4b and 5 with extrahepatic bile duct resection for pT2 gallbladder carcinoma is valid: a single-institution result.

Authors:  Shunsuke Onoe; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Yasuyuki Fukami; Masatoshi Isogai
Journal:  Updates Surg       Date:  2015-08-19

9.  Extrahepatic bile duct resection in gallbladder carcinoma: differentiated discussion about risk and oncological benefit.

Authors:  Ulrich Klaus Fetzner; Ionel Constantin Oana; Dirk L Stippel
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

10.  Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.

Authors:  Andrea Cavallaro; Gaetano Piccolo; Vincenzo Panebianco; Emanuele Lo Menzo; Massimiliano Berretta; Antonio Zanghì; Maria Di Vita; Alessandro Cappellani
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.